Sanofi applauds NIP law change

Immunisation advocates and Sanofi are celebrating the passing of a bill in Parliament that expands the scope of the National Immunisation Program (NIP) to enable non-vaccine immunological treatments to be funded.

To see the whole article, log in or create an account.